Yersinia pestis 195/p antigen (formaldehyde inactivated) is under investigation in clinical trial NCT02596308 (Immunogenicity and Safety of Subunit Plague Vaccine).
- Also known as
- PLAGUE VACCINE
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Yersinia pestis 195/p antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account